Results 171 to 180 of about 3,609,152 (355)
Molecular Oncology, EarlyView.Proteomic and phosphoproteomic analyses were performed on lung adenocarcinoma (LUAD) tumors with EGFR, KRAS, or EML4–ALK alterations and wild‐type cases. Distinct protein expression and phosphorylation patterns were identified, especially in EGFR‐mutated tumors. Key altered pathways included vesicle transport and RNA splicing.
Fanni Bugyi +12 more
wiley +1 more source
Targeting of PTP4A3 overexpression sensitises HGSOC cells towards chemotherapeutic drugs
Molecular Oncology, EarlyView.In HGSOC with normal KRAS expression, high PTP4A3 expression regulates autophagy activation. Conversely, in HGSOC with high KRAS expression, KRAS dictates autophagy control, and PTP4A3 is not required. When high PTP4A3 expression is inhibited, HGSOC cells are preferentially sensitised towards DNA‐damaging agents.
Ana López‐Garza +3 more
wiley +1 more source
Effect of intercellular collisions on red blood cell membrane damage. [PDF]
Sci RepValtchanov H, Cecere R, Mongrain R.
europepmc +1 more source
THE TRANSFER OF POTASSIUM ACROSS THE HUMAN BLOOD CELL MEMBRANE
, 1941 T. S. Danowski
openalex +1 more source
Molecular Oncology, EarlyView.Screening 166 FDA‐approved anticancer drugs identifies the aromatase inhibitor Exemestane as a synergistic partner of PARP inhibitor Olaparib in BRCA‐proficient triple‐negative breast cancer. Exemestane induces ROS‐mediated replication stress, enhancing DNA damage and apoptosis alongside Olaparib.
Nur Aininie Yusoh +5 more
wiley +1 more source
Application of Biomimetic Cell Membrane-Coated Nanocarriers in Cardiovascular Diseases. [PDF]
Int J NanomedicineZhao X +6 more
europepmc +1 more source
THE TRANSFER OF INORGANIC PHOSPHORUS ACROSS THE RED BLOOD CELL MEMBRANE
, 1936 Lena Halpern
openalex +1 more source
A Model Representing a Physiological Role of CO2 at the Cell Membrane [PDF]
, 1961 D. F. Sears, R. M. Eisenberg
openalex +1 more source